H-REDEDEIEW-NH2

Ref. 3D-PP43065

Produktinformation

• Name: H-REDEDEIEW-NH2
• Synonyme: NH2-Arg-Glu-Asp-Glu-Asp-Glu-Ile-Glu-Trp-amide

Beschreibung

Peptide H-REDEDEIEW-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-REDEDEIEW-NH2 include the following: Virtual screening using covalent docking to find activators for G245S mutant p53 SI Omar , MG Lepre, U Morbiducci , MA Deriu - PLoS , 2018 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0200769 Tetramer formation of tumor suppressor protein p53: Structure, function, and applications R Kamada , Y Toguchi, T Nomura, T Imagawa - Peptide , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.22772 Stabilization of Mutant Tetrameric Structures by Calixarene Derivatives R Kamada , R Kamada - Tetramer Stability and Functional Regulation of , 2012 - Springerhttps://link.springer.com/chapter/10.1007/978-4-431-54135-6_3 Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide N Issaeva, A Friedler , P Bozko - Proceedings of the , 2003 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1835733100 p53-A natural cancer killer: Structural insights and therapeutic concepts L Römer, C Klein , A Dehner, H Kessler - Angewandte Chemie , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/anie.200600611 p53-ein naturlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte L Römer, C Klein , A Dehner, H Kessler - Angewandte , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ange.200600611 Emerging non-canonical functions and regulation by p53: p53 and stemness DJ Olivos III, LD Mayo - International journal of molecular sciences, 2016 - mdpi.comhttps://www.mdpi.com/1422-0067/17/12/1982 The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy D Gouas, H Shi, P Hainaut - Cancer letters, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304383509001694

• Marke: Biosynth